[Experience with turbulent magnetic field as a component of breast cancer therapy].

{
  "study_type": "randomized_trial",
  "exposure": {
    "band": null,
    "source": "turbulent magnetic field (TMF) as component of preoperative chemoradiotherapy",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Patients with locally advanced breast cancer (T3, N1–N3, M0) receiving preoperative chemoradiotherapy",
  "sample_size": 114,
  "outcomes": [
    "Antitumor effect / treatment effectiveness (clinical, roentgenological, histological end-results)",
    "Adverse side-effects",
    "Postoperative lymphorrhea duration and extent"
  ],
  "main_findings": "In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.",
  "effect_direction": "benefit",
  "limitations": [
    "Randomization not described in the abstract despite the publication type listing 'Clinical Trial'",
    "No exposure parameters reported (e.g., field strength, frequency, duration)",
    "No comparator/control group described",
    "Outcomes are described qualitatively without effect sizes or statistical details"
  ],
  "evidence_strength": "low",
  "confidence": 0.66,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "turbulent magnetic field",
    "TMF",
    "breast cancer",
    "preoperative chemoradiotherapy",
    "clinical trial",
    "lymphorrhea"
  ],
  "suggested_hubs": []
}